The Mechanisms of Forcing- Eye-Open-at-Birth Rats Limbal Stem Cell Deficiency Caused by Lipid Peroxidatio by 张兆强
  
学校编码：10384                                  分类号     密级    









The Mechanisms of Forcing- Eye-Open-at-Birth Rats Limbal 
Stem Cell Deficiency Caused by Lipid Peroxidation 
 
张 兆 强 
指导教师姓名：陈永雄  教授 
专 业 名 称 ：生   理   学 
论文提交日期：2016 年 11 月 
论文答辩时间：2016 年 12月 
学位授予日期：2016 年    月 
 
答辩委员会主席：  刘祖国教授   
评    阅    人：               
















































































































































另外，该学位论文为（                   ）课题（组）的研究
成果，获得（                                           ）课题




































（ ）1.经厦门大学保密委员会审查核定的保密学位论文，于  年 


























中文摘要   
背景：角膜（cornea）是眼睛前端的一层透明组织，角膜上皮（corneal 
epithelium）位于角膜的最外层，传统观点上认为角膜上皮的自我更新能力主要




alpha（peroxisome proliferators-activated receptor alpha，PPARα）在脂代谢中发
挥着重要作用，非诺贝特（fenofibrate，Fen）是 PPARα 的激动剂，可以促进脂








组 15 只；第二部分实验采用非诺贝特处理 FEOB 大鼠角膜 10 天，观察其对
FEOB 角膜缘干细胞缺乏是否有治疗作用，本实验共分为 3 组：Normal 组、
（FEOB+PBS）组和（FEOB+Fen）组，每组大鼠 15 只。实验采用裂隙灯检
查，HE 染色和 PAS 染色观察其组织病理学形态；采用油红 O 染色检测角膜表
面的中性游离脂肪酸；实时荧光定量逆转录-聚合酶链式反应（Real-time 
fluorescent quantitative reverse transcription polymerase chain reaction，qRT-PCR）
和蛋白免疫印迹（Western blotting）检测 LSC 的标志物（P63、ABCG2）、脂类
代谢相关因子[PPARα、肉碱棕榈酰基转移酶（carnitine palmitoyltransferase 1 
alpha，Cpt1）、脂酰辅酶 A 合酶（long chain acyl-CoA synthetase，Acsl）、脂酰
















水合酶（short chain enoyl-CoA hydratase，Ech）]、脂质过氧化相关因子 5-脂氧







阳性，LSC 标志物 P63、ABCG2 表达下调，角膜特异性角蛋白 K12 表达下
降，K10、K13 表达上调，角膜上皮基底层 PCNA 阳性细胞数显著下降，符合
角膜缘干细胞缺乏诊断标准；FEOB 大鼠角膜表面油红 O 染色阳性，说明角膜
表面出现脂类沉积，与此同时调控脂类代谢的核受体 PPARα 表达下调，脂质代
谢相关酶类 Cpt1α、Acsl、Acadm 和 Ech 的表达也下调；脂质过氧化酶 ALOX5
表达上调，脂质过氧化产物 MDA 增多，表明脂类代谢异常，脂质发生过氧
化；  
第二部分：与 FEOB+PBS 组对照，Fenofibrate 处理 FEOB 大鼠后，角膜未见溃
疡，新生血管数量减少，PCNA 阳性细胞增多，角蛋白 K12 表达上调，K10、
K13 表达下调，说明 Fenofibrate 可以减轻 LSCD 病症；处理后油红 O 染色转为
阴性，Fenofibrate 作为 PPARα 的激动剂，可以激活 PPARα 表达，上调 Cpt1α、
Acsl、Acadm 和 Ech 的表达，促进脂类 β 氧化；角膜中的 ALOX5 和 ALOX5ap
均表达下调，脂质过氧化的产物 MDA 含量下降。 
结论：新生大鼠开睑之后，角膜微环境发生改变，角膜表面出现脂类沉积，同






















Abstract   
Background：  Corneal epithelium is located at the outermost layer of cornea, a  
transparent tissue in front of the eye. The traditional view believes that cornea epithelia 
are renewed constantly by the adult stem cells which are located in the limbus. Limbal 
stem cell deficiency（LSCD）is clinically characterized by a classic triad of signs, 
including corneal opacity, conjunctivalization, neovascularization and vision 
impairments. LSCD is caused by a number of genetic,  environmental or incidental 
factors; however, the pathogenesis of LSCD is not well illustrated. Lipid is one of the 
major metabolisms in the body. Peroxisome proliferators-activated receptor alpha
（PPARα） plays an important role in lipid metabolism. Fenofibrate, as a PPARα agonist, 
promotes fatty acid β oxidation. Abnormal lipid metabolism causes lipid peroxidation，
which harms the body.  
Objective: To uncover the relationship between abnormal lipid metabolism and LSCD, 
lipid accumulation , peroxidation and the role of PPARα in conreal epithelium were 
thoroughly analyzed during the process of LSCD induced by FEOB.   
Methods: The study were divided into two parts: the first part was to study the alterations 
of corneal lipid metabolism and lipid peroxidation in the process of LSCD induced by 
FEOB, the second part was to investigate the therapeutic effect of fenofibrate in FEOB 
rat cornea. For the first study, the rats were randomly divided into normal and FEOB 
group，and in each group rats were further divided into six subgroups: P0, P1, P5, P10, 
P15 and P30. Each group contained 15 animals. In the second study, the experiments were 
conducted to compare three groups: normal control group,（FEOB + PBS）group and
（FEOB + Fen）group, with 15 animals in each group. Histopathological changes were 
monitored by slit lamp examination, H&E staining and PAS staining. The neutral free 
fatty acids in the surface of cornea were detected by Oil Red O staining. The expression 
of LSC markers (P63, ABCG2), cytokeratin (K10, K12, K13), factors of lipid metabolism
（PPARα, Cptα, Acs, Acadm and Ech）, and enzyme of lipid peroxidation(ALOX5) were 
detected by qRT-PCR and Western blotting. The localization of PPARα in cornea was 
measured by in situ hybridization. TUNEL staining was used to detect cell apoptosis. The 
















inflammatory cells (ED1 and PMN) were detected by immunohistochemistry. Moreover, 
the content of malondialdehyde (MDA) and the activity of superoxide dismutase (SOD) 
were measured with assay kits.  
Results: In the first part of study, the cornea of FEOB rats demonstrated low transparency, 
neovascularization, corneal epithelium pathological hyperplasia and arrangement 
disorder compared with normal rats. PAS staining was positive, indicating corneal 
conjunctivalization. The expression level of LSC markers P63 and ABCG2 was reduced ; 
corneal specific keratin K12 was down-regulated while ectopic K10 and K13 were 
upregulated. The number of PCNA-positive cells in central epithelium and limbus was 
significantly reduced. Compared with normal cornea, the deposition of lipid was detected 
on the corneal surface of FEOB rats, observed by positive Oil Red O staining. 
Furthermore, the expression of PPARα, Cpt1α、Acs、Acadm and Ech were down-
regulated, while ALOX5 expression and lipid peroxidation product (MDA) were 
increased, indicating the occurrence of abnormal lipid metabolism. In second part of study, 
after treatment of Fenofibrate（Fen） the FEOB rats showed no corneal ulcer and 
neovascularization in the（FEOB+Fen）group, compared with（FEOB + PBS）group. 
It was also demonstrated that the number of PCNA positive cells were increased, togrther 
with up-regulation of K12 expression and down-regulation of K10 and K13. The Oil Red 
O staining was negative in the （FEOB+Fen）group. Fenofibrate activated PPARα、
Cpt1α、Acs、Acadm and Ech expression.Tn addition ,the expression of ALOX5 and the 
content of MDA were decreased inzhe FEOB rats.  
Conclusion: Corneal microenvironment was altered by FEOB, and lipid was deposited 
in the surficial corneal epithetlium. Meanwhile, PPARα was down-regulated and 
consequently lipid β oxidation was inhibited, and lipid peroxidation which was found on 
the surface leads to limbal stem cell damage, and eventually LSCD. Fenofibrate activated 
the expression of PPARα, accelerated lipid metabolism, and reduced lipid peroxidation, 
Therefore, fenofibrate shows the potential to protect limbal stem cell and treat LSCD in 
ocular surface disorders.  
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（embryonic stem cell，ESC）和成体干细胞（somatic stem cell，SSC）[5]；根据
发育潜能不同，干细胞可以分为以下三类：全能干细胞（totipotent stem cell，
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